About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Metformin Therapy in HCV Infection | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT02972723

Metformin Therapy in HCV Infection

Hepatitis C virus infection (HCV) is a major cause of cirrhosis and death from liver disease worldwide. Current therapy for HCV with interferon based therapies results in cure rates of around 5055% wh...

Lead sponsor: Nottingham University Hospitals NHS Trust•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Nottingham University Hospitals NHS Trust

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adult Males and Females (18-70 yrs old) able to give consent
•Chronic hepatitis C virus infection
•Women of child bearing potential (who have a negative pregnancy test) must agree to use methods of medically acceptable forms of contraception during the study; (e.g.intra-uterine device (IUD) or a double-barrier method of oral contraception with condom)

Exclusion Criteria

•Type 2 diabetes.
•Patients with impaired renal function.
•Decompensated liver cirrhosis (stable patients with cirrhosis would be eligible).
•Patients who in the opinion of the Investigator are considered unsuitable.
•Pregnant females.

Related studies

TERMINATEDPhase 3

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV

NCT01866930 · Chronic Hepatitis C Infection

Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions

NCT02333292 · Chronic Hepatitis C Infection

COMPLETEDPhase 3

A Study to Evaluate Chronic Hepatitis C Infection

NCT01716585 · Chronic Hepatitis C Infection

COMPLETEDPhase 3

A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis

NCT01704755 · Chronic Hepatitis C Infection, Compensated Cirrhosis

COMPLETEDPhase 3

A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis

NCT02219503 · Chronic Hepatitis C Infection, Compensated Cirrhosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 23, 2016Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment16

Start dateMar 2011

Last updatedNov 23, 2016

Condition

Chronic Hepatitis C Infection

Locations shown

Secondary care Hepatitis clinic at Nottingham University Hospital

Nottingham, Nottingham

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 23, 2016Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions